Sofinnova Investments, Inc. Portfolio Holdings

Sofinnova Investments, Inc.

  • $1.06 Billion
  • Q3 2024

Sofinnova Investments, Inc. has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.06 Billion distributed in 62 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $197M, Vera Therapeutics, Inc. with a value of $123M, Novo Nordisk A S with a value of $86.5M, Astrazeneca PLC with a value of $63.1M, and Ideaya Biosciences, Inc. with a value of $55.4M.

Examining the 13F form we can see an decrease of $745M in the current position value, from $1.8B to 1.06B.

Sofinnova Investments, Inc. is based out at Menlo Park, CA

Below you can find more details about Sofinnova Investments, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $1.06 Billion
Healthcare: $1.06 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$15.7B
$197 Million 18.64% of portfolio
1,550,280
Q4 2023 Reduced 50.0%
$1.15B
$123 Million 11.68% of portfolio
2,793,987
Q4 2023 Added 24.09%
$200B
$86.5 Million 8.18% of portfolio
726,329
Q3 2024 Added 11.82%
$206B
$63.1 Million 5.97% of portfolio
809,406
Q3 2024 Added 1.0%
$1.23B
$55.4 Million 5.24% of portfolio
1,749,455
Q3 2024 Added 51.92%
$5.51B
$51.7 Million 4.89% of portfolio
3,518,684
Q3 2024 Added 22.85%
$15.3B
$47.2 Million 4.47% of portfolio
714,176
Q3 2024 New
$3.89B
$34.1 Million 3.23% of portfolio
379,527
Q3 2024 Added 22.35%
$362M
$28.8 Million 2.73% of portfolio
2,194,278
Q4 2019 Added 4.28%
$1.24B
$27.7 Million 2.62% of portfolio
772,070
Q3 2024 Reduced 52.51%
$516M
$24.5 Million 2.31% of portfolio
2,265,230
Q3 2024 Reduced 18.32%
$368M
$24 Million 2.27% of portfolio
5,662,550
Q3 2024 Added 5.67%
$120M
$22.4 Million 2.12% of portfolio
4,280,308
Q4 2023 Added 17.1%
$7.71B
$21 Million 1.99% of portfolio
188,562
Q3 2024 New
$9.54B
$20.9 Million 1.98% of portfolio
286,307
Q3 2024 Added 25.71%
$740M
$15.1 Million 1.43% of portfolio
786,999
Q3 2024 Reduced 63.46%
$46.3B
$13.4 Million 1.27% of portfolio
202,898
Q3 2024 Reduced 71.98%
$129B
$11.4 Million 1.08% of portfolio
135,819
Q3 2024 Reduced 20.61%
$661M
$11.1 Million 1.05% of portfolio
600,302
Q3 2024 Reduced 0.2%
$1.94B
$10.3 Million 0.97% of portfolio
384,767
Q3 2024 Reduced 19.11%
$133M
$9.89 Million 0.94% of portfolio
676,766
Q3 2024 Added 3.22%
$3.24B
$9.32 Million 0.88% of portfolio
406,645
Q3 2024 New
$3.86B
$9.21 Million 0.87% of portfolio
203,271
Q3 2024 Reduced 55.33%
$4.68B
$8.39 Million 0.79% of portfolio
358,644
Q3 2024 Reduced 80.73%
$61.9M
$7.86 Million 0.74% of portfolio
3,758,686
Q2 2021 New
$971M
$7.84 Million 0.74% of portfolio
181,476
Q3 2024 Reduced 57.72%
$2.37B
$7.49 Million 0.71% of portfolio
164,770
Q3 2024 New
$69.1M
$7.24 Million 0.68% of portfolio
1,533,883
Q3 2024 Added 25.69%
$603M
$5.8 Million 0.55% of portfolio
296,884
Q3 2024 Reduced 64.02%
$441M
$5.36 Million 0.51% of portfolio
238,184
Q3 2024 Added 0.5%
$21.2B
$5.3 Million 0.5% of portfolio
40,611
Q3 2024 New
$310M
$5.03 Million 0.48% of portfolio
1,842,668
Q3 2024 Added 8.42%
$522M
$4.41 Million 0.42% of portfolio
386,100
Q3 2024 Reduced 51.54%
$2.96B
$3.72 Million 0.35% of portfolio
90,327
Q3 2024 Reduced 42.04%
$64.6B
$3.66 Million 0.35% of portfolio
15,191
Q3 2024 New
$26.9M
$3.66 Million 0.35% of portfolio
2,671,856
Q1 2021 New
$206B
$3.57 Million 0.34% of portfolio
5,770
Q3 2024 New
$10.5B
$2.56 Million 0.24% of portfolio
37,637
Q3 2024 Reduced 79.3%
$18.8M
$1.79 Million 0.17% of portfolio
2,754,437
Q1 2021 New
$1.66B
$1.4 Million 0.13% of portfolio
30,472
Q3 2024 Added 42.23%
$145M
$942,000 0.09% of portfolio
85,640
Q3 2024 Added 41.11%
$974M
$968,000 0.09% of portfolio
129,246
Q3 2024 New
$56.2M
$661,000 0.06% of portfolio
382,616
Q4 2023 Reduced 5.0%
$616M
$527,000 0.05% of portfolio
48,138
Q3 2024 New
$229M
$516,000 0.05% of portfolio
62,313
Q3 2024 Added 3.43%
Achieve Life Sciences Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 9.05%
Arrivent Bio Pharma Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Bio Age Labs Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 41.35%

Summary

  • Portfolio
  • No. of Stocks 62
  • Current Value $1.06 Billion
  • Prior Value $1.8 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 11 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 15 stocks
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email